SLQT

Business Context and Reporting Period

Company: SelectQuote, Inc. (SLQT)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended June 30, 2024
Business Overview: SelectQuote is a technology-enabled, direct-to-consumer (DTC) distribution platform for insurance policies (Senior, Life, Auto & Home) and healthcare services (SelectRx, Population Health). The company earns commissions from insurance carriers for policies sold and generates revenue from pharmacy services. It does not underwrite insurance risk.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 32% year-over-year (YoY) to $1.32 billion. This was driven by a 94% surge in Pharmacy revenue ($464.9 million) and a 12% increase in Commissions and other services revenue ($856.9 million).
• Profitability Improvement: The company narrowed its net loss from $58.5 million in FY2023 to $34.1 million in FY2024. Operating income turned positive at $64.6 million, compared to $11.6 million in the prior year.
• Segment Performance:
  • Senior: Revenue grew 11% to $655.8 million; Adjusted EBITDA increased 8% to $166.7 million.
  • Healthcare Services: Revenue grew 90% to $478.5 million. Adjusted EBITDA improved significantly from a loss of $22.8 million to a profit of $7.8 million.
  • Life: Revenue grew 8% to $157.9 million; Adjusted EBITDA decreased 13% to $20.2 million due to higher operating costs.
  • Auto & Home: Revenue grew 66% to $36.2 million; Adjusted EBITDA increased to $14.1 million.
• Debt Service: Interest expense increased 16% to $93.6 million due to higher interest rates and accrued interest payable in kind on Term Loans.

Guidance, Outlook, and Risks

• Strategic Realignment: Effective July 1, 2024, the company will remove the Auto & Home business as a separate reportable segment, consolidating it into "Other." This decision reflects a strategic shift to reduce revenue growth in that segment due to high industry rates and a focus on positive cash flow.
• Liquidity and Debt: The company has $688.2 million in outstanding Term Loans. Management believes cash available under the Senior Secured Credit Facility is sufficient for the next 12 months but explicitly states it does not expect to generate sufficient cash flows to repay all outstanding amounts at maturity (September 15, 2025, per recent amendment). Refinancing or additional capital will be required.
• Key Risks:
  • Carrier Concentration: Three carriers (UHC, Humana, Aetna) accounted for 63% of total revenue in FY2024. Relationships are non-exclusive and terminable on short notice.
  • Regulatory Environment: The Senior segment is heavily regulated by CMS; changes in Medicare marketing rules or compensation limits could materially impact operations.
  • Revenue Recognition Estimates: Revenue relies on significant estimates regarding Lifetime Value (LTV) of commissions, including persistency and lapse rates. Adjustments to these estimates can cause volatility in reported revenue.

Investor Verification Checklist

• Debt Maturity: Verify the terms of the "Tenth Amendment" to the credit facility and the company's concrete plan for refinancing the $688 million debt maturing in 2025.
• Pharmacy Margins: Assess the sustainability of the 94% revenue growth in the Healthcare Services segment and monitor gross margins given the high cost of goods sold ($405 million).
• Carrier Concentration: Monitor the stability of relationships with UHC, Humana, and Aetna, which collectively drive the majority of revenue.
• Revenue Adjustments: Review future filings for "cohort adjustments" or "tail adjustments" to commission revenue, as changes in persistency assumptions can materially alter earnings.
• Auto & Home Strategy: Confirm the impact of downgrading the Auto & Home segment on overall revenue growth targets and resource allocation.